Keep Up With Global Black News

Sign up to our newsletter to get the latest updates and events from the leading Afro-Diaspora publisher straight to your inbox.

BY Nduta Waweru, 6:01am May 31, 2018,

Report reveals shocking “bluetoothing” habit among drug addicts in South Africa [Video]

by Nduta Waweru, 6:01am May 31, 2018,
The users hope to get some of nyaope's effect from another person's blood. Photo: Sky News

Drug addicts in South Africa, who do not have enough money for the drug of their choice, have invented a new way to get high.

The process, called Bluetoothing, involves multiple drug users injecting blood from another user who has taken a hit of the drug.

Sky News video captured the drug users taking a deadly cocktail of drugs called nyaope.  The cocktail is a combination of heroin, antiretroviral drugs and even crushed glass and rat poison. After injecting it, they pull blood out of their veins and share it with others for them to also get high.

The effect is almost instantaneous, giving the users the high they were looking for. However, according to one of the users known as Jesus, the high does not last for long.

“Maybe an hour or two,” said Jesus. “Sometimes less than an hour.”

Researchers have stated that bluetoothing may not be effective because the potency of the drug has reduced once it gets into the bloodstream.

Although there have been efforts by the South African National Council on Alcoholism and Drug Dependence to deal with the issue, more users are still looking for these drugs. Worse even, they are adding more dangerous products to the nyaope cocktail.

Besides drug addiction and dependence, the drug users are at risk of catching diseases, including HIV.

Last Edited by:Ismail Akwei Updated: May 31, 2018

Conversations

Must Read

Connect with us

Join our Mailing List to Receive Updates

Face2face Africa | Afrobeatz+ | BlackStars

Keep Up With Global Black News and Events

Sign up to our newsletter to get the latest updates and events from the leading Afro-Diaspora publisher straight to your inbox, plus our curated weekly brief with top stories across our platforms.

No, Thank You